About
MYoroface AB is a healthtech company based in Hudiksvall, Sweden, founded in 2012. The company specializes in the development of IQoro, a patented neuromuscular training device aimed at addressing the root causes of various health conditions, including reflux, heartburn, snoring, and swallowing difficulties. IQoro is a Class I CE-marked medical device designed for self-administration, allowing users to engage in a specific exercise regimen to improve orofacial and swallowing muscle function. The company emphasizes a solution-focused approach to treatment, providing an app to support users in their training and offering a results guarantee. IQoro has been clinically validated through over 20 years of research, with significant improvements reported by patients. Since its approval for prescription in the UK National Health Service in 2022, IQoro has been adopted in over 100 NHS hospitals and 650 primary care clinics, and it is also available for direct purchase in several European countries.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2012
-
Annual Revenue $7000000
Location
14 Sjoetullsgatan, Hudiksvall, Gavleborg County, Sweden, 824 50